Publicacions en col·laboració amb investigadors/es de Universidad Autónoma de Madrid (30)

2021

  1. Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Adults in Madrid, Spain

    Clinical Infectious Diseases

2020

  1. Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity

    International Journal of Infectious Diseases, Vol. 97, pp. 290-292

2018

  1. Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain

    European Journal of Gastroenterology and Hepatology, Vol. 30, Núm. 9, pp. 1060-1062

2017

  1. Hepatitis delta and HIV infection

    AIDS, Vol. 31, Núm. 7, pp. 875-884

2016

  1. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection

    Liver International, Vol. 36, Núm. 9, pp. 1258-1266

  2. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

  3. Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

    Journal of Translational Medicine, Vol. 14, Núm. 1

  4. Short communication: CXCL12 rs1029153 polymorphism is associated with the sustained virological response in HIV/Hepatitis C virus-coinfected patients on Hepatitis C Virus therapy

    AIDS Research and Human Retroviruses, Vol. 32, Núm. 3, pp. 226-231

2015

  1. TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients

    Journal of Clinical Virology, Vol. 65, pp. 62-67

2014

  1. PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy

    Journal of Acquired Immune Deficiency Syndromes, Vol. 67, Núm. 2, pp. 113-119

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2011

  1. Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype

    HIV Medicine, Vol. 12, Núm. 8, pp. 487-493

  2. The expansion ability but not the quality of HIV-specific CD8 + T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors

    Immunology, Vol. 134, Núm. 3, pp. 305-313

2004

  1. Benefits in the lipid profile after substitution of abacavir for stavudine: A 48-week prospective study

    AIDS Research and Human Retroviruses, Vol. 20, Núm. 12, pp. 1289-1292

  2. Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus-Infected Patients with Chronic Hepatitis C: A European Collaborative Study

    Clinical Infectious Diseases, Vol. 38, Núm. 1, pp. 128-133

2003

  1. First-line therapy and mitochondrial damage: Different nucleosides, different findings

    HIV Clinical Trials, Vol. 4, Núm. 1, pp. 11-19

  2. Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy

    AIDS, Vol. 17, Núm. 6, pp. 921-924

2001

  1. Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients

    Intervirology, Vol. 44, Núm. 6, pp. 339-343

  2. Role of nonnucleosides in the development of HAART-related lipid disturbances [3]

    Journal of Acquired Immune Deficiency Syndromes

2000

  1. Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy

    Virus Research, Vol. 66, Núm. 1, pp. 13-26